Atlas Trials

Yuan Yuan

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yuan Yuan

RecordFirmDate
Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer (NCT07552181)Yuan Yuan2026-09-01
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer (NCT05318469)Yuan Yuan2023-10-13
Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer (NCT03025035)Yuan Yuan2017-09-10

Track Yuan Yuan automatically

Every clearance here is in the API, with alerts when new ones post.